591P Survival and benefit of adjuvant chemotherapy (ACT) by circulating tumor DNA (ctDNA)-based genomic profile and molecular residual disease (MRD) in resectable colorectal oligometastases (CRM): PRECISION, a prospective multicenter study

Shin Kobayashi, Yoshiaki Nakamura, Akio Shiomi et al.|Annals of Oncology|2023

Cited by 5